Clinical Trials Logo

Filter by:
NCT ID: NCT02768090 Withdrawn - Clinical trials for Application Site Perspiration

Proteomic Analysis of Sweat in Cutaneous Conditions

Start date: February 25, 2016
Phase: N/A
Study type: Interventional

This study will investigate a new diagnostic technology in order to expand current understanding of inflammatory and neoplastic cutaneous disease processes such as eczema, psoriasis, granuloma annulare, cutaneous lymphoma, squamous cell carcinoma, basal cell carcinoma and melanoma. Protein fragments found in sweat will be collected using a diagnostic skin patch and analyzed with mass spectrometry. The goal of this study is to identify specific protein fragment biomarkers that may further current understanding of cutaneous diseases. The protein expression patterns derived from sweat will be compared to conventional histopathologic, immunohistochemical, flow cytometry, in-situ hybridization, polymerase chain reaction, and mass spectrometry analyses of cutaneous biopsy specimens. The insight gained from this research will be used to promote advances in disease prevention and early diagnosis, identify prognostic indicators and new therapeutic targets.

NCT ID: NCT02767349 Withdrawn - Acute Pain Clinical Trials

Pharmacokinetics and Safety of MNK-155 in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain

Start date: January 2016
Phase: Phase 1
Study type: Interventional

An open-label study of the pharmacokinetics (PK) and safety of MNK-155 in postsurgical adolescent subjects aged 12 to 17 years with moderate to severe acute pain. The study will assess the safety of administering multiple doses of MNK-155 in this population.

NCT ID: NCT02767024 Withdrawn - Acute Heart Failure Clinical Trials

Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure

PRIORITY-ADHF
Start date: May 1, 2018
Phase: Phase 4
Study type: Interventional

Single center, prospective, randomized, non-blinded research study comparing intravenous vasodilator infusion vs. inotropic infusion in patients admitted to the hospital or in the emergency room at Montefiore Medical Center presenting with the diagnosis of acute decompensated systolic heart failure with low cardiac output but no hypotensive.

NCT ID: NCT02766842 Withdrawn - Lymphoma Clinical Trials

Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore)

Start date: April 2016
Phase: Phase 2
Study type: Interventional

Diagnosis of lesions of pancreas, the upper gastrointestinal tract, as well as adjacent structures, such as lymph nodes, is still showing advancements especially with the increased use of endoscopic ultrasound. Endoscopic ultrasound-guided fine needle aspiration and fine needle biopsy (EUS-FNA/FNB) have become mainstay diagnostic techniques for these lesions. The purpose of the study is to compare between the currently used, ProCore needles and the new biopsy needle, SharkCore, for the histological diagnosis and evaluation of lesions.

NCT ID: NCT02765997 Withdrawn - Clinical trials for Acute Myeloid Leukemia

StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies

Start date: April 2017
Phase: Phase 2
Study type: Interventional

This is an open label, interventional, randomized phase II trial comparing StemRegenin-1 (SR-1) cultured umbilical cord blood (experimental arm) to unmanipulated umbilical cord blood (standard of care arm) transplantation after a myeloablative CY/FLU/TBI conditioning. A 2:1 randomization will be employed with a higher chance of being assigned to the experimental arm.

NCT ID: NCT02765815 Withdrawn - Clinical trials for Osteoarthritis, Knee

A Comparison of Exparel Local Anesthetic in Total Knee Arthroplasty (TKA) Patients

Start date: February 2016
Phase: Phase 4
Study type: Interventional

This is a prospective, single-center, single-blinded, randomized, case-control study. The study is conducted by a single investigator at an orthopedic surgery institute, with a minimum 6 week post operative follow-up period of TKA patients who receive Exparel compared with the surgeon's standard method (detailed below) for pain management intraoperatively.

NCT ID: NCT02765425 Withdrawn - Healthy Elderly Clinical Trials

Training the Brain With a Robotic Device for Balance Recovery

Start date: August 30, 2017
Phase: N/A
Study type: Interventional

The research objective of this study is to determine whether an intervention and associated robotic device called "Assisted Movement with Enhanced Sensation (AMES) can be used to enhance balance recovery following an unexpected loss of balance by conditioning areas of the brain involved in lower-limb (LL) motor control. It is hypothesized that AMES can improve balance recovery, gait, and reduce falls in near-frail elderly people by improving LL strength, speed, and coordination. AMES, is a medical intervention and robotic device originally developed to aid patients' recovery from injuries to the central nervous system that limit movement. Earlier published studies demonstrated a unique property of AMES, namely that it is capable of reducing sensorimotor impairment in the severely impaired, an underserved population of patients with brain and spinal cord injuries. AMES applies assisted movement, biofeedback, and sensory stimulation simultaneously and non-invasively to the upper or lower limb, the initial intent being to address impairments such as weakness, spasticity, sensory loss, and dyssynergia (i.e., co-contraction). These reductions in impairment are achieved through cortical plasticity. In the present study, the same methodology will be applied to the lower limbs of the near-frail elderly to reduce falls by training faster reaction times, stronger reactions, and more coordinated recoveries from slips and trips

NCT ID: NCT02763761 Withdrawn - Lung Cancer Clinical Trials

An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo

Start date: August 16, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the effects of Infliximab and oral prednisone versus methylprednisolone and oral prednisone in patients with melanoma, lung cancer, or renal cell carcinoma who have immune related Grade 3-4 diarrhea for up to 3 days or persistent Grade 2 diarrhea for more than 5 days after treatment with Yervoy and/or Opdivo

NCT ID: NCT02760615 Withdrawn - Crohn Disease Clinical Trials

Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

Start date: November 1, 2016
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate in a step-wise approach the disease drug-drug interaction (DDI) potential for vedolizumab to indirectly affect the exposure of cytochrome P-450 (CYP) substrate drugs by modulating pro-inflammatory cytokines in participants with ulcerative colitis (UC) or Crohn's disease (CD) who are treated with vedolizumab.

NCT ID: NCT02759549 Withdrawn - Breast Cancer Clinical Trials

Fatigue in Breast Cancer Patients Undergoing Radiotherapy-eSMART-MH

Start date: September 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if an avatar-based depression self-management intervention (eSMART-MH) once a week for the duration of the participant's radiation treatment will significantly reduce depressive symptoms. Investigators also seek to explore how women with breast cancer describe their mood using prompted and unprompted speech through electronic social media and interviews. Participants will be randomized into the eSMART-MH group or the theater testing (attention control) group. In addition to the assigned interventions, participants will be asked to complete questionnaires and interviews with the study staff.